Delivery Order SPE2DB22D2006-SPE2DB25FW3AK
- Not listed
- The Defense Logistics Agency awarded a $12,600 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 150 mg/ml medroxyprogesterone. As the prime contractor, Amerisourcebergen will supply the pharmaceutical product to the DLA under a one-day contract spanning August 24-25, 2023. Amerisourcebergen, a subsidiary of Amerisourcebergen Corporation, will perform the order from its facility in Conshohocken, Pennsylvania. No subcontractors or set aside designations were identified....
- The Defense Logistics Agency awarded a $731.60 delivery order contract to Amerisourcebergen Drug Corporation for the provision of 150 mg/ml medroxyprogesterone. The firm fixed price contract has a period of performance from July 11, 2023 through July 12, 2023 and will be performed in Conshohocken, Pennsylvania. No additional details were provided regarding the original solicitation or whether this delivery order was issued against an existing indefinite-delivery/indefinite-quantity contract...
- This is a $1,562.48 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of 4,568,212,074 milliliters of medroxyprogesterone 150 mg/ml, a medication, with an ultimate completion date of May 13, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
- The Defense Logistics Agency awarded a $67,260 firm fixed price delivery order to Amerisourcebergen Drug Corporation for the provision of 150 mg/ml medroxyprogesterone. The single day contract has a period of performance from July 24, 2023 through July 25, 2023 and will be performed in Conshohocken, Pennsylvania. As a major provider of pharmaceuticals and medical supplies to the Department of Defense, this order for the generic hormone drug is consistent with DLA's role in supporting essential...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,237.38 contract is for the delivery of 4,568,119,737 milliliters of the medication Medroxyprogesterone 150 mg/ml. The award has an ultimate completion date of May 5, 2025. AmerisourceBergen holds a substantial $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which...
- The Defense Logistics Agency awarded a delivery order valued at approximately $629 to Amerisourcebergen Drug Corporation for the supply of 150 mg/ml medroxyprogesterone. As the prime contractor, Amerisourcebergen will deliver the medication to a location in Conshohocken, Pennsylvania under a firm fixed price contract executed from August 17 to August 18, 2023. The parent company, Amerisourcebergen Corporation, will perform through its corporate office division. No subcontractors or set aside...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of medroxyprogesterone 150 mg/ml, a medication, with a ceiling value of $1,105.35 and a period of performance through June 16, 2025. The contract is a firm fixed-price delivery order, without any set-aside designation, indicating open competition. Amerisourcebergen Drug Corp...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,772.99 fixed-price delivery order contract is for the supply of Medroxyprogesterone, a pharmaceutical drug. The contract has an ultimate completion date of January 6, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
- The Defense Logistics Agency awarded a $423,840 firm fixed price delivery order to Amerisourcebergen Drug Corporation for the provision of 150 mg/ml medroxyprogesterone. The single day contract has a period of performance from June 21, 2023 through June 22, 2023 and will be performed in Conshohocken, Pennsylvania. Amerisourcebergen will supply the pharmaceutical product to the DLA, the Department of Defense's combat logistics support agency, in support of its mission to provide medical...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the supply of Medroxyprogesterone 150 mg/mL. The contract has a firm fixed price, with a ceiling value of $3,016.81, and a performance period through July 3, 2025. The contract is not set aside and was awarded on July 2, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with...
- SPE2DB22D2006Indefinite Delivery Contract
- SPE2DB22D2006-SPE2DB25FW3AKDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Medroxyprogesterone 150 mg/mL, a hormone treatment medication, valued at $7,627.72 under a firm fixed price contract. The delivery order was competitively awarded without set-aside designation and is scheduled for completion by August 1, 2025. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen Drug Corp maintains its corporate headquarters and serves as a major pharmaceutical distributor for federal medical procurement needs. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The parent contract functions as a comprehensive global pharmaceutical support vehicle enabling the company to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. Through this vehicle, AmerisourceBergen Drug Corp maintains a significant role in the Defense Logistics Agency's medical supply chain operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $7.6k | 7/31/25 |